
Husband to @tarablelawyer❤️. Urologic Oncologist. Sehn Professor and Chair of Urology @GUUrology @MedStarHealth @GUMedCenter. VIEWS MINE!
Washington, DC
Joined September 2010
- Tweets15.5K
- Following2.2K
- Followers4.4K
- Likes29.2K
Pinned Tweet
🚨 Registration is open for MedStar Health Advances in Urologic Oncology 2026!
Join us in Washington, DC, Oct 16–17 for two packed days covering the rapidly changing landscape of #ProstateCancer, #BladderCancer & #KidneyCancer.
Surgery. Radiation. Systemic therapy. Imaging. Genomics. Biomarkers. Interactive tumor boards. Nationally recognized faculty.
📍 Park Hyatt Washington, DC
⏰ Early bird registration ends Sept 7
🎓 12.75 CME
Register 👇
medstar.cloud-cme.com/course…
This is just straight up negligence. He could have died. @NFL do you really care about patient safety at all?
Keith Kowalczyk, MD retweeted
Was great fun learning with all of you - thanks @KeithKow and @MedStarHealth for inviting me to talk Prostate Pathology!
Great time at @MedStarHealth Uro Onc conference. Outstanding talks and great times with friends. Thanks KK!
Not sure if this counts as a @TylerSbrt 🏃 by 💦 though 😬
Had a great time, see you all next time!!
Great time at @MedStarHealth Uro Onc conference. Outstanding talks and great times with friends. Thanks KK!
Not sure if this counts as a @TylerSbrt 🏃 by 💦 though 😬
Keith Kowalczyk, MD retweeted
Seriously great conference @KeithKow
Great time at @MedStarHealth Uro Onc conference. Outstanding talks and great times with friends. Thanks KK!
Not sure if this counts as a @TylerSbrt 🏃 by 💦 though 😬
Keith Kowalczyk, MD retweeted
An essay worth reading, for every clinician and patient (with a PrCa paragraph)
The Quiet Half of Good Medicine jamanetwork.com/journals/jam…
Keith Kowalczyk, MD retweeted
Chef opens a restaurant. People really like it. He books out reservations for 3 months.
But now people are upset there’s a 3 month wait to go to the restaurant.
Then, the government decides to put price caps at how much he can charge customers. He still needs to pay overhead and staff and ingredients, though.
So he decides he needs to serve more customers to cover his costs. So he shortens the allowable time for meals. Of course, now the customers aren’t happy about having to rush through their meals. Many of them insist on eating at a leisurely pace, or they send their food back because they didn’t like it, or they show up late for their reservation and insist on being seated anyway.
Meanwhile, the chef is trying to keep up. He feels bad he can’t put the same attention into each meal he did before. But if he doesn’t serve enough people in a day, he will have to close down (or sell to the large restaurant conglomerate down the street).
Oh, and the government also decides that he now needs to do two hours of computer work for every hour he spends cooking. They force him to use a terrible, but expensive, computer system, too, not the one he wanted. So he needs to serve even more customers to cover those costs as well.
The customers are rightly upset. They’re waiting longer and getting less personalized service. The chef is also upset that he’s spending more on overhead but delivering worse meals.
Nobody is happy here.
Keith Kowalczyk, MD retweeted
Time to remind everyone of the inpatient cost of radiation cystitis that radiation therapy comes bundled with. pubmed.ncbi.nlm.nih.gov/3816…
Keith Kowalczyk, MD retweeted
When "cancer" is a diagnosis but not really a disease
A slightly more philosophical piece than my usual—on what we mean by cancer, and whether the word itself can sometimes do more harm than good.... let me know what you think!
Many thanks @pam3001 @aeonmag
aeon.co/essays/we-need-a-bet…
Keith Kowalczyk, MD retweeted
An unthinkable tragedy in our community cbsnews.com/pittsburgh/news/…
Wowwwwwwww!!!
Breaking News from @TheAthleticFC: Manchester City have been found guilty on all but one of the 115 charges relating to breaches of the Premier League’s financial regulations, according to people briefed on the matter. nyti.ms/3TmkLe6
Keith Kowalczyk, MD retweeted
Ask hard questions. Demand real data. Challenge assumptions. That’s how medicine gets better.
But some of what passes for “scientific discourse” online lately is just contempt with extra steps.
Skepticism sharpens a field. Disagreement advances it. Cruelty doesn’t.
A privilege to be a part of this team. Any donations to provide basic surgical supplies are appreciated. A little truly goes a long way.
This is the fourth time @KeithKow
and I have led a team to Ghana. We continue to teach and capacity build with great urologists on the ground. If you have some spare cash we would love your help.
donorbox.org/support-ivu-s-w…
Keith Kowalczyk, MD retweeted
Some thoughts, welcoming feedback:
1. If the frontier labs feel obligated to build something they think is dangerous because China is going to build it anyway, we'd better be really sure that China is going to build it anyway. Like, really, really, really sure.
Are we? Are we actually sure? The CCP wants to build an out-of-control, recursively self-improving model bc its neurotically, control-obsessed government thinks this is a policy worth pursing? We're 100% sure about that?
2. At the very least, we know that Chinese models distill American models to keep up with the frontier. So, any slowdown by the US seems like it would mechanically and automatically slow the ability of China to distill its way to progress. If we're afraid of the rate of progress, isn't that a good thing?
It's been a while since I've been on X (thanks @CanesDavid and @jimhumd...). Now I'm mad about everything again!!!!!!!!!
Keith Kowalczyk, MD retweeted
🚨 Exercise improved QoL for patients on ADT for #prostatecancer & it costs less per QALY than most cancer drugs the NHS funds 🚨
🏋️♂️@TheLancetOncol STAMINA trial:
👥 700 men on ADT, median age 71.6, 34% metastatic, 19% on ARPI or chemo
📊 Randomized 5:4 vs an ACTIVE comparator: optimised usual care w/ clinician training and behavioural prompts
💊 12 mo supervised aerobic + resistance exercise in community gyms, dietary advice, behavioural support, free membership
✅ FACT-P +4.5 (p=0.0004), FACT-G +3.7, above the >3 point clinically important threshold
✅ Fatigue (FACIT-F) +1.9 (p=0.0068)
✅ £13,920 to £19,077 per QALY. Median ICER for NICE-approved oncology drugs: £30,000
⚠️ Open label PROs, 97% of pts White, fatigue effect at the edge of MCID, physical outcomes unchanged
⚠️ 3 intervention-related SAEs, all recovered
🎯 This beat an already-enhanced control, in a population including metastatic pts, delivered through community gyms at scale.
👉I think many of us have been telling patients for years to exercise while on ADT to reduce side effects, now we have trial-grade data!
*The figure in this post is not from the paper, based on tabular data!!!
🔗 doi.org/10.1016/S1470-2045(2…
@AmerUrological @UroOnc @SUO_YUO @PCFnews @urotoday @UrologyTimes @CaPsurvivorship
Congrats to @DrFAbdollah and team on genuine 10-yr follow-up of a real RCT — rare and valuable, though at n=60/arm, randomization for continence outcomes can't fully protect against chance baseline imbalance in pathology. However, reporting outcomes honestly deserves real credit.
Worth reading past the headline:
• Post hoc analysis — trial was designed/powered for continence, not oncologic outcomes
• Surgeons were highly experienced anteriorly but early in their RS learning curve
• pT3 disease 45% (RS) vs 23% (anterior); PSM 25% vs 13%
• Only 9 patients remained at risk at the 10-yr mark
• Authors fairly call it "hypothesis-generating"
Good data, not a verdict. Bigger, prospective, contemporary RCTs will tell us more.
Long-term Oncological Outcomes of Retzius-sparing Versus Anterior Robot-assisted Radical Prostatectomy: Post Hoc Analysis of a Randomized Cohort by Alfonso Santangelo ...Firas Abdollah et al
buff.ly/OZUURYD
Thank you to all the authors for trusting EUO to publish your work!
@santangelo_alfo
@DrFAbdollah
@pr.morgan.roupret
@ric_campi89
@laura.marandino
@jteoh_hk
@davdandrea
@renu.eapen
@uroweb
@gu_cast_podcast
@oncoalert
@elsevier_oncology
@elsevier_connect
Day 2 breaks down complex surgical innovations, systemic sequencing options, and collaborative care pathways for advanced cases.
Insights from Dr. Michael Atkins and faculty
@SabyGeorgeMD @MGuptaMD @UroOncDC @akfsurgeon (3/3)




























